PCR144 Mosaic: A Qualitative Study of the Humanistic and Financial Burden on Unpaid Caregivers of Patients with Geographic Atrophy (GA)

Autor: W Amoaku, D Altman, SP Sarda, B Lui, J Carpenter-Conlin, P Marquis, A Rams, R Desgraz, T Lovell, DL Jones, JS Nielsen

Publikováno v: Value in Health. 25:S568

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e0a918732bd6fadaef63c7ed7550a1b4
https://doi.org/10.1016/j.jval.2022.04.1487

POSA29 A New Patient-Focused Progression Model for Geographic Atrophy

Autor: RP Singh, W Stevens, M Crowell, D Crabb, DL Jones, M Intorcia, SP Sarda

Publikováno v: Value in Health. 25:S23

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::248069b392042bc204c709205bf7521a
https://doi.org/10.1016/j.jval.2021.11.102

Real-World Healthcare Resource Utilization, Healthcare Costs, and Injurious Falls Among Elderly Patients with Geographic Atrophy.

Autor: Sarda SP; Apellis Pharmaceuticals, Waltham, MA, USA., Germain G; Groupe d'analyse, Ltée, Montreal, Québec, Canada., Mahendran M; Analysis Group, Inc, Boston, MA, USA., Klimek J; Analysis Group, Inc, Boston, MA, USA., Cheng WY; Analysis Group, Inc, Boston, MA, USA., Luo R; Apellis Pharmaceuticals, Waltham, MA, USA., Duh MS; Analysis Group, Inc, Boston, MA, USA.

Publikováno v: Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2024 Nov 09; Vol. 18, pp. 3215-3226. Date of Electronic Publication: 2024 Nov 09 (Print Publication: 2024).

A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis.

Autor: Mendivil J; Takeda Pharmaceuticals International AG, Zurich, Switzerland., DerSarkissian M; Analysis Group, Inc., Boston, MA, USA., Banerji A; Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Diwakar L; Department of Immunology, University Hospitals of North Midlands, Stoke-on-Trent, UK., Katelaris CH; Campbelltown Hospital, Western Sydney University, Campbelltown, NSW, Australia., Keith PK; McMaster University, Hamilton, ON, Canada., Kim H; McMaster University, Hamilton, ON, Canada.; Department of Medicine, Western University, London, ON, Canada., Lacuesta G; Halifax Allergy and Asthma Associates, Halifax, NS, Canada., Magerl M; Institute of Allergology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany., Slade C; Department of Clinical Immunology and Allergy, Royal Melbourne Hospital, Melbourne, VIC, Australia., Smith WB; Department of Clinical Immunology and Allergy, Royal Adelaide Hospital, Adelaide, SA, Australia., Choudhry Z; Takeda Development Center Americas, Lexington, MA, USA., Simon A; Takeda Development Center Americas, Lexington, MA, USA. angela.simon@takeda.com., Sarda SP; Takeda Development Center Americas, Lexington, MA, USA., Busse PJ; Division of Allergy and Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Publikováno v: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology [Allergy Asthma Clin Immunol] 2023 May 29; Vol. 19 (1), pp. 48. Date of Electronic Publication: 2023 May 29.

Burden of Treatments for Respiratory Complications in Extremely Premature Infants: Interviews with Caregivers.

Autor: Sarda SP; Global Evidence and Outcomes, Takeda Development Center Americas, Lexington, MA, USA., Vanya M; Global Evidence and Outcomes, Takeda Development Center Americas, Lexington, MA, USA.; ICON, South San Francisco, CA, USA., Schwartz EJ; ICON, Gaithersburg, MD, USA., Sorrells K; NICU Parent Network, Madison, MS, USA., Namba F; Department of Pediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan., Hirano S; Department of Neonatal Medicine, Osaka Women's and Children's Hospital, Osaka, Japan., McNulty A; TinyLife, Belfast, UK., Han L; Clinical Development, Takeda, Cambridge, MA, USA., Mangili A; Global Programs, Takeda Pharmaceuticals International AG, Zurich, Switzerland.

Publikováno v: Biomedicine hub [Biomed Hub] 2023 Jan 27; Vol. 8 (1), pp. 15-24. Date of Electronic Publication: 2023 Jan 27 (Print Publication: 2023).